155 related articles for article (PubMed ID: 31986937)
21. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
[TBL] [Abstract][Full Text] [Related]
22. Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway.
Wang XM; Liu XM; Wang Y; Chen ZY
Bioengineered; 2021 Dec; 12(1):117-126. PubMed ID: 33315500
[TBL] [Abstract][Full Text] [Related]
23. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
[TBL] [Abstract][Full Text] [Related]
24. Keloid pathogenesis via Drosophila similar to mothers against decapentaplegic (SMAD) signaling in a primary epithelial-mesenchymal in vitro model treated with biomedical-grade chitosan porous skin regenerating template.
Lim CK; Halim AS; Yaacob NS; Zainol I; Noorsal K
J Biosci Bioeng; 2013 Apr; 115(4):453-8. PubMed ID: 23177217
[TBL] [Abstract][Full Text] [Related]
25. LINC01116 regulates proliferation, migration, and apoptosis of keloid fibroblasts by the TGF-β1/SMAD3 signaling via targeting miR-3141.
Wu D; Zhou J; Tan M; Zhou Y
Anal Biochem; 2021 Aug; 627():114249. PubMed ID: 34048784
[TBL] [Abstract][Full Text] [Related]
26. Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-
He L; Zhu C; Dou H; Yu X; Jia J; Shu M
Dis Markers; 2023; 2023():9638322. PubMed ID: 37091895
[TBL] [Abstract][Full Text] [Related]
27. ADAM17 regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the EGFR/ERK signaling pathway.
Le X; Fan YF
J Plast Surg Hand Surg; 2023; 57(1-6):129-136. PubMed ID: 34978504
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
Zhang Y; Zhang L; Lin XH; Li ZM; Zhang QY
Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
[TBL] [Abstract][Full Text] [Related]
29. TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars.
Bran GM; Sommer UJ; Goessler UR; Hörmann K; Riedel F; Sadick H
Anticancer Res; 2010 Sep; 30(9):3459-63. PubMed ID: 20944123
[TBL] [Abstract][Full Text] [Related]
30. Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-β1/Smad and MAPK signaling pathways.
Cui J; Jin S; Jin C; Jin Z
Life Sci; 2020 Aug; 254():117326. PubMed ID: 31954164
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
[TBL] [Abstract][Full Text] [Related]
32. EGR1/NOX4 pathway regulates oxidative stress and further facilitates fibrosis progression in keloids responses to TGF-β1.
Qin H; Zhang L; Li M; Liu Y; Sun S; Nie W; Bai B; Li G; Zhang G
J Dermatol Sci; 2022 Dec; 108(3):138-145. PubMed ID: 36608994
[TBL] [Abstract][Full Text] [Related]
33. Human umbilical cord mesenchymal stem cell-derived exosomes suppress dermal fibroblasts-myofibroblats transition via inhibiting the TGF-β1/Smad 2/3 signaling pathway.
Hu J; Chen Y; Huang Y; Su Y
Exp Mol Pathol; 2020 Aug; 115():104468. PubMed ID: 32445750
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
35. Impact of MiR-21 on the expression of FasL in the presence of TGF-β1.
Wang X; Liu Y; Chen X; Zhang M; Xiao Z
Aesthet Surg J; 2013 Nov; 33(8):1186-98. PubMed ID: 24335017
[TBL] [Abstract][Full Text] [Related]
36. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
[TBL] [Abstract][Full Text] [Related]
37. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars.
Phan TT; Lim IJ; Chan SY; Tan EK; Lee ST; Longaker MT
J Trauma; 2004 Nov; 57(5):1032-7. PubMed ID: 15580028
[TBL] [Abstract][Full Text] [Related]
38. NADPH oxidase-2 is a key regulator of human dermal fibroblasts: a potential therapeutic strategy for the treatment of skin fibrosis.
Zhang GY; Wu LC; Dai T; Chen SY; Wang AY; Lin K; Lin DM; Yang JQ; Cheng B; Zhang L; Gao WY; Li ZJ
Exp Dermatol; 2014 Sep; 23(9):639-44. PubMed ID: 24981855
[TBL] [Abstract][Full Text] [Related]
39. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
40. High temperature requirement factor A1 (HTRA1) regulates the activation of latent TGF-β1 in keloid fibroblasts.
Jin SF; Wang YX; Xu N; Sun Q; Wang CC; Lv MZ; Sun X; Guo S
Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):107-110. PubMed ID: 29412803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
